Log in
About us
Join
Donate
Contact us
Home
Membership
Join Today!
Member Benefits
Career Center
Education
Registration
WebRounds Schedule 2024
Virtual Standard HRA Course 2024
HRA Course Overview
HRA Course Faculty
HRA Q&A Forum
Virtual Advanced HRA Course 2024
Advanced HRA Course Faculty
Advanced HRA Q&A Forum
HRA Clinical Workshop
Scientific Meeting 2025
Registration Details and Fees
Meeting Program
Venue & Travel
Abstracts
Abstract Terms and Conditions
Abstract Submission
Past Abstract Publication
Past Scientific Meeting Photos
ECHO Hub 2024
Other Courses
Patient Support
Basic Facts
Resource Materials
General Info on HPV
HPV Immunization
General Info on Anal Cancer and Precancer
Info Related to Procedures
Useful Educational Resource Sites and Organizations
Support Services
Patient Seminars
Pathology
Pathology PowerPoint - p16 Immunoreactivity
Pathology PowerPoint - Classifying AIN2 Lesions
Pathology PowerPoint - Reading between the lines - Helpful hints in understanding pathology reports
About Us
Board of Directors
IANS Committees
Mission Statement
Bylaws
IANS Financials
Goals
Reply to: Patients of Transgender Experience Following DX of Anal Cancer
*
Mandatory
fields
Author
*
Body
<blockquote><strong class="quote">Anonymous wrote:</strong><p><span style=""><em>Transgender women are at a higher risk of anal cancer, though there is uncertain relationship to hormones and further research must be done.</em></span></p> <p><span style="">Hillary Dunlevy, MD<br> Advanced HRA Course Director</span></p><br></blockquote><br>
You can use basic HTML tags.
Body should be less than 50 kilobytes
The International Anal Neoplasia Society
P.O. Box 1543
Leesburg, Virginia 20177
info@iansociety.org
Powered by
Wild Apricot
Membership Software